Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,682.2
29.2 (1.10%)

 

  • STI Straits Times Index
    2,682.2
    29.2 (1.10%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.6
    18.9 (1.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,167.5
    794.4 (3.13%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,316.6
    163.8 (5.20%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,702.0
    395.5 (1.77%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,995.2
    21.5 (0.43%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 834.2M
  • Value: 529.8M
  • Rise: 228
  • Fall: 65
  • Unch: 515

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Singapore-eDev0.121+0.006
Rex Intl0.186+0.006
Medtecs Intl0.590+0.090
LionGold0.002-
Yoma Strategic0.320+0.005
Synagie0.197+0.006
MDR0.001-
AnAn Intl0.070+0.006
ThaiBev0.715+0.020
KOP0.069+0.008

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SUPERMX SUPERMAX CORPORATION BHD
Quotes 15 Minutes Delayed. Updated at 06 Jul 2020 14:00
Last (MYR): 10.420 Change: +1.010 High: 10.480 Remarks:
Change (%): +10.73 Low: 9.460
Open 9.500 Yesterday's Close 9.410
Buy Price 10.940 Sell Price 9.900
Buy Volume ('00) 3 Sell Volume ('00) 2
Cumulative Volume ('00) 286,147 Cumulative Value 283,948,945
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a 0.09533 Trailing EPS (MYR) e 0.10920 NAV (MYR) b 0.9619
PE a 109.305 Trailing PE f 95.419 Price / NAV b 10.8327
Dividend (MYR) d - Cash In Hand (MYR) g 0.1691 Issued & Paid-up Shares c 1,291,422,000
Dividend Yield (%) d - Price / Cash In Hand g 61.620 Treasury Shares h 68,888,000
Beta - 75 Daysi 1.523 R-Squared - 75 Days(%)i 13.67 Market Cap (M) 13,456.617
Beta - 500 Daysi 1.207 R-Squared - 500 Days (%)i 9.09 Enterprise Value (M) 13,722.223
Piotroski F Score 8 Exchange Code 7106 Par Value ( MYR ) n.a.
52 Weeks Volatility (%) 80.67 6-Month VWAP 3.914 Free Float (%) 55.5
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Medical Specialties
Index Components BM HEALTH CARE / FBM EMAS / FBM EMAS SHARIAH / FBM MID 70 / FBM TOP 100
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 30 Apr 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 30 Apr 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SUPERMX Bursa 13,456.617 109.305 95.419 10.8327 -
Industry HEALTH CARE EQUIPMENT & SERVICES Bursa 1,816.044 125.058 94.385 16.0502 0.190
Medical Specialties Bursa 31,640.783 136.542 102.953 17.6818 0.152
Index BM HEALTH CARE Bursa 11,591.751 106.910 108.044 5.6387 0.391
FBM EMAS Bursa 5,126.879 20.642 24.200 1.3317 3.174
FBM EMAS SHARIAH Bursa 4,787.237 33.638 40.951 1.6792 2.319
FBM HIJRAH SHARIAH Bursa 18,481.871 27.732 37.165 1.8330 2.472
FBM MID 70 Bursa 4,534.190 24.767 28.521 1.1842 2.645
FBM TOP 100 Bursa 13,334.683 20.287 23.216 1.5600 3.075
Local Peer HARTA Bursa 57,392.822 132.003 132.004 22.5867 -
Local Peer TOPGLOV Bursa 55,443.549 152.039 85.407 16.4298 0.346
Local Peer LKL Bursa 270.144 - - - -
Global Peer ABBOTT LABORATORIES NYSE 163,141.035 44.501 46.098 5.3988 1.426
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 144,508.621 39.099 39.386 5.0600 0.210
Global Peer DANAHER CORP NYSE 127,293.757 51.147 46.508 4.3216 0.372
Global Peer MEDTRONIC PLC NYSE 124,955.508 26.092 26.092 2.4628 2.318
Global Peer BECTON DICKINSON & CO NYSE 69,460.859 64.197 76.331 3.3157 1.199
Global Peer STRYKER CORP NYSE 68,945.862 33.099 31.860 5.2570 1.160
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,694.417 49.079 48.831 7.9578 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 50,548.467 10.755 11.791 3.6619 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,375.588 44.331 43.463 5.7638 0.970
Global Peer EDWARDS LIFESCIENCES CORP NYSE 42,874.552 40.954 38.702 10.9904 -
Other Global Peers KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), IDEXX LABORATORIES INC (NASDAQ), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), STERIS PLC (NYSE), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), Top Glove (SGX), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), WEIGAO GROUP (HKEx), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), COCHLEAR LTD (ASX), MICROPORT (HKEx), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), GLOBUS MED INC (NYSE), KANGJI MEDICAL (HKEx), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), AK MEDICAL (HKEx), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), PEIJIA-B (HKEx), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), INARI MEDICAL INC (NASDAQ), EBOS GROUP (ASX), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), KDL MEDICAL (HKEx), AXONICS MODULATION TECHNLOGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), SILK ROAD MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), LIFETECH SCI (HKEx), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CIRC (HKEx), ACCELERATE DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ZYNEX INC (NASDAQ), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), YESTAR HEALTH (HKEx), CORMEDIX INC (NYSE American), CYTOSORBENTS CORP (NASDAQ), VIEWRAY INC (NASDAQ), PW MEDTECH (HKEx), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), MEDICAL DEVELOPMENT INTL (ASX), ALPHATEC HLDGS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), STEREOTAXIS INC (NYSE American), GOLDEN MEDITECH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ALPHA PRO TECH (NYSE American), MISONIX INC (NASDAQ), INVACARE CORP (NYSE), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), SIENTRA INC (NASDAQ), Medtecs Intl (SGX), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), UG Healthcare (SGX), APYX MEDICAL CORPORATION (NASDAQ), MODERN DENTAL (HKEx), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), VINCENT MED (HKEx), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), CELSION CORPORATION (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), YUNNAN ENERGY (HKEx), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), Biolidics (SGX), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), DIMERIX LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), ONCOCYTE CORP (NYSE American), COMPUMEDICS (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESONANCE HEALTH LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), KELFRED (HKEx), ZOSANO PHARMA CORP (NASDAQ), RESPIRI LTD (ASX), MOTUS GI HOLDINGS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IMMUCELL CORP (NASDAQ), NEOVASC INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEURONETICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), Yunnan Energy (SGX), MICRO-X LTD (ASX), ELECTROCORE INC (NASDAQ), LBT INNOVATIONS LTD (ASX), IRIDEX CORP (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), METALICITY LIMITED (ASX), NEUROTROPE INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), LIFE HEALTHCARE (HKEx), MYOS RENS TECHNOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), AETHLON MEDICAL INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), AVINGER INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), ENDOLOGIX INC (NASDAQ), CYANOTECH CORP (NASDAQ), OPTISCAN IMAGING (ASX), DIGIRAD CORP (NASDAQ), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), Annica (SGX), ADHERIUM LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ANALYTICA (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DORSAVI LTD (ASX), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), OBALON THERAPEUTICS INC (NASDAQ), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+3.570
+52.12 %
10 Days -+3.020
+40.81 %
20 Days -+1.540
+17.34 %
Medium Term Return 3 Months -+8.830
+555.35 %
6 Months -+9.050
+660.58 %
1 Year -+8.760
+527.71 %
Long Term Return 2 Years 0.035+8.180
+366.74 %
3 Years 0.125+9.445
+981.54 %
5 Years 0.170+9.415
+953.73 %
Annualised Return Annualised --
+60.16 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.290 - 9.430 Change From 1 Year Low +9.130 % Change From 1 Year Low (%) +707.75
Change From 1 Year High +0.990 % Change From 1 Year High (%) +10.50
2 Years Range 1.290 - 9.430 Change From 2 Years Low +9.130 % Change From 2 Years Low (%) +707.75
Change From 2 Years High +0.990 % Change From 2 Years High (%) +10.50
5 Years Range 0.845 - 9.430 Change From 5 Years Low +9.575 % Change From 5 Years Low (%) +1133.14
Change From 5 Years High +0.990 % Change From 5 Years High (%) +10.50
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Supermax Corporation Berhad is a leading international manufacturer, distributor and marketer of high quality medical gloves. Established in 1987, its founders started a trading business to distribute latex gloves and eventually ventured into the manufacturing of latex gloves in 1989. Today, the Supermax Group has eight factories manufacturing various types of latex gloves, which are exported to over 145 countries around the world, such as the United States of America, European Union, Middle East, Asia and South Pacific countries.



IPO Performance

Listing Date 07 Aug 2000 Full Subscription Rate (x) -
No of Placement Shares (M) - No of Public Offer Shares (M) 6.10 Public Offer Subscription Rate (x) -
IPO Price (MYR) 2.000 First Day Close (MYR) 1.626 First Week Close (MYR) 1.291
Current vs IPO Price (%) +421.00 First Day Gain (%) -18.70 First Week Gain (%) -35.45

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Jun 2019 Part 1(1.54 MB)
Annual Report 2018 Jun 2018 Part 1(2.15 MB)
Part 2(0.62 MB)
Annual Report 2017 Jun 2017 Part 1(0.86 MB)
Annual Report 2016 Jun 2016 Part 1(2.06 MB)
Annual Report 2014 Dec 2014 Part 1(1.47 MB)
Annual Report 2013 Dec 2013 Part 1(1.93 MB)
Part 2(0.29 MB)
Annual Report 2012 Dec 2012 Part 1(2.78 MB)
Annual Report 2011 Dec 2011 Part 1(2.70 MB)
Annual Report 2010 Dec 2010 Part 1(2.25 MB)
Annual Report 2009 Dec 2009 Part 1(1.39 MB)
Part 2(0.05 MB)
Annual Report 2008 Dec 2008 Part 1(1.00 MB)
Annual Report 2007 Dec 2007 Part 1(0.84 MB)
Annual Report 2006 Dec 2006 Part 1(3.19 MB)
Annual Report 2005 Dec 2005 Part 1(1.39 MB)
Part 2(0.54 MB)
Annual Report 2004 Dec 2004 Part 1(1.03 MB)
Part 2(0.20 MB)
Part 3(0.24 MB)
Annual Report 2003 Dec 2003 Part 1(0.74 MB)
Part 2(0.23 MB)
Annual Report 2002 Dec 2002 Part 1(0.64 MB)
Annual Report 2001 Dec 2001 Part 1(0.74 MB)
Part 2(0.63 MB)
Part 3(1.08 MB)
Part 4(0.51 MB)
Part 5(1.29 MB)
Part 6(1.72 MB)
Annual Report 2000 Dec 2000 Part 1(0.49 MB)
Part 2(0.85 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
03 Jul 2020 9.100 9.430 8.810 9.410 37,147,100 9.2123
02 Jul 2020 8.500 9.130 8.500 8.960 43,718,300 8.8681
01 Jul 2020 8.140 8.530 8.050 8.490 32,702,000 8.3321
30 Jun 2020 7.860 8.380 7.780 8.000 45,872,500 8.1187
29 Jun 2020 6.940 7.850 6.700 7.720 35,399,000 7.3493
26 Jun 2020 7.170 7.220 6.810 6.850 21,099,800 6.9403
25 Jun 2020 7.010 7.310 7.000 7.110 20,276,500 7.1530
24 Jun 2020 7.350 7.430 7.120 7.120 13,013,600 7.2478
23 Jun 2020 7.600 7.630 7.300 7.380 20,067,000 7.4278
22 Jun 2020 7.330 7.720 7.300 7.510 23,003,400 7.5766
19 Jun 2020 6.700 7.470 6.610 7.400 37,027,800 7.1746
18 Jun 2020 7.220 7.320 6.500 6.930 51,534,500 6.8059
17 Jun 2020 7.470 7.490 7.060 7.210 15,515,700 7.2222
16 Jun 2020 7.410 7.590 7.100 7.320 38,012,700 7.3463
15 Jun 2020 8.050 8.050 6.760 6.870 58,739,400 7.2819
12 Jun 2020 7.500 8.410 7.480 7.910 33,074,200 8.2208
11 Jun 2020 8.610 9.000 8.050 8.250 35,671,500 8.4603
10 Jun 2020 8.590 8.820 8.330 8.550 15,468,400 8.6405
09 Jun 2020 9.150 9.300 8.610 8.650 24,578,100 8.9506
05 Jun 2020 8.500 8.900 8.250 8.880 39,993,500 8.7113
04 Jun 2020 7.120 8.200 6.700 8.200 34,242,100 7.8235
03 Jun 2020 7.500 7.580 5.330 7.140 82,702,800 6.8833
Summary
Current 2 Weeks
(22 Jun 2020 to 03 Jul 2020)
7.330 9.430 6.700 9.410 292,299,200 -
Previous 2 Weeks
(05 Jun 2020 to 19 Jun 2020)
8.500 9.430 6.700 7.400 349,615,800 -
4 Weeks from
(04 May 2020 to 04 Jun 2020)
2.470 9.430 2.450 8.200 746,164,600 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.